Sales and Marketing

Showing 15 posts of 11527 posts found.

AstraZeneca reveals Alderley Park plan

May 8, 2013 Research and Development, Sales and Marketing AstraZeneca, BioCity, R&D, alderley

AstraZeneca has left a key question about what to do with its soon-to-be defunct R&D site in Cheshire in the …

New UK head at Porter Novelli

May 8, 2013 Medical Communications, Sales and Marketing Porter Novelli, smiddy

PR firm Porter Novelli has announced that Mary Smiddy has been named as its new UK head of health & …

Funding boost for GSK open lab

May 7, 2013 Research and Development, Sales and Marketing GSK, Wellcome

GlaxoSmithKline has been given an extra £5 million by the Wellcome Trust to help support its work in Spain on …

Lessons from the business gurus

May 7, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing MSI, buffet, business gurus

Marketing books are full of pithy quotes from business gurus, quotes which are often repeated until they almost become mantras. …

FleishmanHillard appoints two directors

May 7, 2013 Medical Communications, Sales and Marketing FleishmanHillard

Comms firm FleishmanHillard has added two directors to its Healthcare leadership team. Robert Hanvik and Alison Wright have joined the …

FDA approves Liptruzet

May 7, 2013 Sales and Marketing FDA, Merck, liptruzet

Merck is celebrating after its once-daily anti-cholesterol pill Liptruzet was approved by US regulators, expanding its indications. The drug – …

Sanofi’s performance dives

May 3, 2013 Sales and Marketing Q1, Sanofi

Sanofi suffered a grim first three months of 2013, with sales dipping and profit plummeting as loss of exclusivity took …

Sanofi appoints two executive members

May 3, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sanofi, executive

Sanofi has announced a new commercial organisation which results in the appointment of two executives. Following the retirement of Hanspeter …

Lundbeck moves ahead in Q1

May 3, 2013 Sales and Marketing Lexapro, Lundbeck, Otsuka, Q1

Lundbeck’s sales and profit increase in the first three months of 2013 was due largely to one-off payments it received, …

Boehringer and OBT in cancer tie-up

May 2, 2013 Research and Development, Sales and Marketing Boehringer, Cancer, OBT

Boehringer Ingelheim and UK biotech firm Oxford BioTherapeutics (OBT) have signed a deal to discover novel antibody targets in cancer. …

Court rules against EMA disclosure

May 2, 2013 Medical Communications, Research and Development, Sales and Marketing AbbVie, EMA, Roche, transparency

The European Medicines Agency (EMA) has been ordered in an interim ruling by the General Court of the European Union …

Not-for-profit comms agency adds special advisor

May 1, 2013 Medical Communications, Sales and Marketing Comprehensive communications

A new not-for-profit marketing and comms consultancy that specialises in healthcare and research has added Professor Martin Gibson to its …

GSK abandons Parkinson’s drug

May 1, 2013 Research and Development, Sales and Marketing GSK, IPX066, Parkinson's

GlaxoSmithKline has terminated its three-year old agreement with Impax Pharmaceuticals to develop investigational Parkinson’s disease drug IPX066. “The decision has …

Life appoints new executive

May 1, 2013 Medical Communications, Sales and Marketing Anderson, Life

Creative comms agency Life Healthcare Communications has appointed a new account executive as part of the expansion of its client …

Charity: MS treatment is ‘lottery’

May 1, 2013 Sales and Marketing MS, lottery, society

Multiple sclerosis care in the UK is a ‘lottery’ according to research by the MS Society. The charity says that …
The Gateway to Local Adoption Series

Latest content